COVID-19 Vaccine Rollout in Canada - Sourcing and Manufacturing

Of the 7 suppliers of COVID-19 vaccines across Canada, only 2 have manufacturing sites in Canada. Details on Canada’s approach to sourcing and manufacturing for COVID-19 vaccines have been presented below.

Canada’s Approach to Sourcing and Manufacturing for COVID-19 Vaccines

Insights on Canada’s COVID-19 Vaccine sourcing and manufacturing

Negotiating the Purchase of Locally Manufactured Vaccines

  • Negotiating the purchase of 148 million doses from Sanofi and GSK, and Medicago, companies that have local COVID-19 manufacturing sites in Canada, will enable quick distributions of these vaccines once approved.

Slow Supply of Vaccine Negotiated

  • Of the 20 million Pfizer-BioNTech vaccine doses negotiated (approved Dec 9th, 2020), only 249,000 doses had been delivered on January 6th. This level of efficiency could be considered very poor in comparison to other first world countries.

Canada Government Close Working with the Private Sector

Glenn is the Lead Operations Research Analyst at The Digital Momentum with experience in research, statistical data analysis and interview techniques. A holder of degree in Economics. A true specialist in quantitative and qualitative research.

COVID-19 Vaccine Rollout in Canada – Administration

Previous article

COVID-19 Vaccine Rollout in Denmark – Sourcing and Manufacturing

Next article

You may also like


Leave a reply

Your email address will not be published.